Charles Rudin

Dr. Charles Rudin is Director of Memorial Sloan Kettering Cancer Center in New York, where he previously served a decade as Chief of the Thoracic Oncology Service. His research focuses on the molecular biology and treatment of lung cancer, with particular emphasis on small-cell lung cancer (SCLC). He has led multiple practice-changing trials in SCLC and NSCLC and is widely recognized for his work on tumor heterogeneity and targeted-therapy resistance mechanisms.